Moleculin CEO, Walter Klemp highlights Annamycin differentiation in the current AML treatment landscape and potential opportunity FRENCHTOWN, NJ / ACCESSWIRE / April 25, 2024 / JTC Team "JTC", a fully integrated corporate communications and investor relations firm, today released a Virtual Investor "What This Means" segment... Lire le communiqué |
|
|
|
|
Live video webcast interactive Q&A with participating companies FRENCHTOWN, NJ / ACCESSWIRE / October 18, 2023 / JTC Team "JTC", a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor "Ask the CEO" Conference, October 2425, 2023.... Lire le communiqué |
|
|
|
|
Access the event and schedule of presenting companies at virtualinvestorco.com Live video webcast presentations of participating companies followed by interactive Q&A session PITTSTOWN, NJ / ACCESSWIRE / January 12, 2022 / JTC Team "JTC", a fully integrated c... Lire le communiqué |
|
|
|
|